Estradiol/testosterone-topical - CellegyAlternative Names: Estrogen/testosterone gel - Cellegy
Latest Information Update: 07 May 2007
At a glance
- Originator Cellegy Pharmaceuticals
- Mechanism of Action Estrogen receptor agonists; Testosterone agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Menopausal syndrome
Most Recent Events
- 07 May 2007 Discontinued - Preclinical for Menopausal syndrome in USA (Topical)
- 12 May 1999 New profile
- 12 May 1999 Preclinical development for Menopausal syndrome in USA (Topical)